Y Hu, X Zhang, Z Zhao, X Chen, Z Zhou,
X Yang… - Toxicology Letters, 2020 - Elsevier
Crizotinib is a multi-target receptor tyrosine kinase inhibitor which is of great importance for
the management of ALK-rearranged non-small cell lung cancer (NSCLC) patients. Serious …